DOCSLIB.ORG

Prevention Practices for Rift Valley Fever (Rvf)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Prevention Practices for Rift Valley Fever (Rvf) PREVENTION PRACTICES FOR RIFT VALLEY FEVER (RVF) If a case of Rift Valley Fever (RVF) is confirmed anywhere in the Specific steps you can take upon RVF being confirmed in the United States, mosquitoes could spread it across the nation. If United States are listed below. Many should already be in any animal on your farm is confirmed to have RVF, all animals place on your farm but should be enhanced and more strictly on the farm that could get sick (cattle, sheep and goats) may enforced in the event that RVF is confirmed in the U.S. This will be euthanized and disposed of to control the further spread of minimize the chance of the disease being introduced onto disease. your farm. There are steps you can take to help reduce the risk of RVF from entering your herd. Strict biosecurity practices can Farm Entrance help you and your neighbors minimize the chances that your animals will have to be destroyed. • Limit access to your farm. - The entrance to your farm is a major control point. A General Precautions handout (found on the CFSPH website) - Have only one gated entrance to the ani- provides prevention steps that should always be used on a mal areas on your farm to better monitor and farm. control all visitors arriving on your farm. The biosecurity practices outlined here should be put into - Keep the gate locked when not in use. place immediately if RVF is confirmed anywhere in the U.S. • Stop all movement of ani- and maintained until the U.S. is once again declared RVF free. mals on and off your farm. - If RVF is confirmed in the U.S., movement re- General Precautionary Measures strictions will most likely be implemented lo- cally, regionally and possibly nationally. Rift Valley Fever is a fever-causing viral disease that severely - Restrictions will depend on the affects cattle, sheep, goats and humans. There is a very high scope of the outbreak. rate of abortion and death in newborn animals. RVF is spread - These measures will minimize the spread of between animals and humans by mosquitoes. A mosquito RVF to other areas, including your farm. will feed on blood from an animal/person with RVF and • Post signs at the farm entrance to in- spread RVF to a new animal when it feeds again. Prevention form visitors. (See Appendix A) measures to minimize the introduction and spread of RVF - Stay off this farm unless given permission to enter. onto your farm fall into four general categories: - Honk before getting out of vehi- 1. Restrict or stop all animal movement to pre- cle (to announce your arrival). vent entry or spread of the disease. - Check-in with farm personnel upon arrival. (Di- 2. Observe, detect and report any dis- rect visitors to “where” they should check-in). ease or unusual signs to your herd vet- - Follow farm biosecurity procedures. erinarian as quickly as possible. - Visitors should avoid contact with ani- 3. Mosquitoes are the most important way that mals unless absolutely necessary. RVF is spread. Control of mosquito breed- ing sites (stock tanks, ponds, old tires etc.) is • Traffic on or off your farm should be closely the key to prevent spread of the disease. monitored and recorded. (See Appendix B) 4. Humans can get Rift Valley Fever. Protect your- - Maintain a log sheet to record all visi- self against mosquito bites and use personal tors and vehicles that enter your farm. protective equipment (respirator, gloves, eye - All visitors should be accompanied by some- protection etc.) when handling tissues from ani- one from your farm at all times. mals that have aborted (placenta, fetus etc.). - Accurate record keeping of traffic on your farm will help with disease surveillance and track- ing should it become necessary. Do not rely on your ability to “recall” visitors and vehicles. RVF_PrevPrac PAGE OF 4 PREVENTION PRACTICES FOR RVF (CONT’D) Mosquito Life Cycle and Control • Check with your local extension office or depart- ment of pest management to determine which Mosquitoes are the most important way that RVF is spread. It pesticides are approved for use in your area. is only the female mosquito that feeds on blood as she needs the protein to produce eggs. Mosquitoes will lay their eggs on or near the edge of water. The mosquito eggs will hatch Animals into larvae (also known as “wigglers”) which turn into pupae (also known as “tumblers”). The larvae and the pupae need Livestock to live in water to survive. The pupae will change into adult mosquitoes. (See Appendix C) • Monitor animals closely and frequently for any developing illness or signs of disease. Control of Mosquito Egg Laying Sites • Educate yourself and train your employ- (See Appendix D) ees about RVF and the signs of illness. - Abortions at any stage of pregnancy, • This is the best way to control mosqui- up to 100% of pregnant animals toes since they lay eggs in specific ar- - Adult cattle: fever, snotty nose, yellow mucus mem- eas and these areas can be managed. branes (gums) or eyes, refusal to eat, diarrhea • Mosquitoes can lay their eggs any place that - Calves: fever, depression, sudden death can hold water. This includes: ponds, old tires, - Adult sheep and goats: snotty nose, diarrhea, yellow tarps, tree holes, bird baths and flower pots. mucus membranes (gums) or eyes, an unsteady gait - Lambs and kids: high fever, de- Control of Mosquito Larvae (“wigglers”) pression, sudden death • Mosquito larvae need to live in wa- • Contact your herd veterinarian imme- ter to survive. They can be found in diately to examine sick animals. any amount of standing water including • Isolate sick animals in a mosquito- ponds, old tires, tarps and bird baths. proof building away from the herd for • Since mosquito larvae remain in the same 30 days to minimize disease spread. water where they hatched from eggs, con- • Any animals that have recently been pur- trol of this stage focuses on continued man- chased or returned to the farm should agement of mosquito egg laying areas. be quarantined for 30 days. • The use of pesticides should only be used - New or returning animals (e.g. shows, as a supplement to controlling mosqui- competitions) can be infected with a dis- toes through the reduction and manage- ease without showing signs right away. ment of mosquito egg laying sites. - Quarantine allows time for a disease to develop in the animal, without exposing your entire herd • Check with your local extension office or depart- to the disease agent. The animal can then be ex- ment of pest management to determine which amined, diagnosed and treated (if it is not RVF). pesticides are approved for use in your area. - Ideally, animals should be quarantined at a separate location (premises). Control of Mosquito Adults • This is the least effective way to control Other Animals mosquitoes. Attempting to control adult • Prevent free roaming animals (dogs, mosquitoes can be difficult and costly. cats) from coming onto your farm. • Control of adult mosquitoes fo- - Dogs and cats can get RVF, and it can cuses on the use of pesticides. be fatal in puppies and kittens. - Infected dogs and cats could serve as a • The use of pesticides should only be source of the RVF virus for mosquitoes to supplemental to controlling mosqui- pass the disease to your livestock. toes through the reduction and manage- - Keep pets in a kennel or tied securely. ment of mosquito egg laying areas. - Ask your neighbors to do the same. RVF_PrevPrac PAGE OF 4 PREVENTION PRACTICES FOR RVF (CONT’D) People • People can get RVF. Infected humans may serve as a source of the virus for mosquitoes which • People can get RVF several ways: could spread the disease to animals or humans. (see Appendix C) - Being bit by a mosquito. • Visitors should park at the entrance - Handling infected animal tissues or fluids. to the farm, away from animal ar- - Breathing in the virus when handling infected eas, or in designated parking areas. animal fluids (blood, birthing tissues and milk). • Specific rules and biosecurity measures to use • Protect yourself against mosquitoes. on farm should be clearly posted for visitors. - When outside, wear long pants and • Record any visitors on the farm with long sleeves to cover skin. a log sheet. (See Appendix B) - Use insect repellants on exposed skin. Repellants • All visitors should be accompanied by with N,N-diethyl-meta-toluamide (commonly known someone from the farm at all times. as DEET) are the most effective. DEET is an in- sect repellant that is safe to use on people but not • Visitors should avoid livestock areas, pens, on pets. Make sure to follow all label directions. barns unless absolutely necessary. - Make sure screens on windows and • If your livestock business depends on visi- doors are in good repair. tors, such as petting farms, or international • Sick animals should not be processed for and local visitors for sales promotion, meat or necropsied during a RVF outbreak. - Ensure that they have not been to ar- - This can release the virus into the air. People eas where RVF has recently occurred. who necropsy the animals or process meat - Visitors from these areas should not be al- may become sick by breathing in the vi- lowed access if they have flu-like illness. rus or by handling the meat and organs. This would include fever, headache, muscle and joint pain, nausea and vomiting. • Wear personal protective equipment, such as gloves, coveralls, boots, protec- tive eyewear and a respirator when han- Record Keeping dling aborted fetuses, birthing tissues, or milking potentially infected animals. • Maintain thorough and accurate re- cords of animal movement.
Load more

Recommended publications
  • A Look Into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins
    viruses Review A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins Shanna S. Leventhal, Drew Wilson, Heinz Feldmann and David W. Hawman * Laboratory of Virology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA; [email protected] (S.S.L.); [email protected] (D.W.); [email protected] (H.F.) * Correspondence: [email protected]; Tel.: +1-406-802-6120 Abstract: In 2016, the Bunyavirales order was established by the International Committee on Taxon- omy of Viruses (ICTV) to incorporate the increasing number of related viruses across 13 viral families. While diverse, four of the families (Peribunyaviridae, Nairoviridae, Hantaviridae, and Phenuiviridae) contain known human pathogens and share a similar tri-segmented, negative-sense RNA genomic organization. In addition to the nucleoprotein and envelope glycoproteins encoded by the small and medium segments, respectively, many of the viruses in these families also encode for non-structural (NS) NSs and NSm proteins. The NSs of Phenuiviridae is the most extensively studied as a host interferon antagonist, functioning through a variety of mechanisms seen throughout the other three families. In addition, functions impacting cellular apoptosis, chromatin organization, and transcrip- tional activities, to name a few, are possessed by NSs across the families. Peribunyaviridae, Nairoviridae, and Phenuiviridae also encode an NSm, although less extensively studied than NSs, that has roles in antagonizing immune responses, promoting viral assembly and infectivity, and even maintenance of infection in host mosquito vectors. Overall, the similar and divergent roles of NS proteins of these Citation: Leventhal, S.S.; Wilson, D.; human pathogenic Bunyavirales are of particular interest in understanding disease progression, viral Feldmann, H.; Hawman, D.W.
    [Show full text]
  • Mapping Rift Valley Fever Vectors and Prevalence Using Rainfall Variations
    VECTOR-BORNE AND ZOONOTIC DISEASES Volume 4, Number 1, 2004 © Mary Ann Liebert, Inc. Research Paper Mapping Rift Valley Fever Vectors and Prevalence Using Rainfall Variations D.J. BICOUT and P. SABATIER ABSTRACT High activity of the Rift Valley Fever (RVF) virus is related to a tremendous increase of associated mosquito vec- tors, which follows periods of high rainfall. Indeed, rainfall creates an ecologically humid environment that in- sures the proliferation of breeding sites and the development of RVF vectors. Data collected by Fontenille et al. (1998) from 1991 to 1996 in the Barkedji area in the northern Senegal are employed to discuss and quantify the in- cidence of rainfall upon the abundances of RVF vectors. We have constructed a non-linear mapping of vector abundances versus rainfall variations, and developed a stochastic model and a corresponding algorithm allowing on output the simulation of RVF mosquito vectors as a function of rainfall trajectories in the course of time. This stochastic mapping of vector abundance is subsequently used to assess the prevalence of RVF in a population of susceptible hosts as a consequence of rainfall. Keywords: Arboviruses—Stochastic dynamics—Rainfall— Vectors— RVF prevalence. Vector-Borne Zoonotic Dis. 4, 33–42. INTRODUCTION severe disease with high mortality and abor- tions in pregnant females. Human infection IFT VALLEY FEVER (RVF) is an arboviral dis- with RVF virus is characterized by the onset of Rease that causes epizootics and associated high fever, hepatitis, encephalitis, haemor- human epidemics throughout Africa (Meegan rhagic fever orocular disease and sometimes and Bailey 1988, Peters and Linthicum 1994). leading to death (Laughlin et al.
    [Show full text]
  • Systematic Review of Important Viral Diseases in Africa in Light of the ‘One Health’ Concept
    pathogens Article Systematic Review of Important Viral Diseases in Africa in Light of the ‘One Health’ Concept Ravendra P. Chauhan 1 , Zelalem G. Dessie 2,3 , Ayman Noreddin 4,5 and Mohamed E. El Zowalaty 4,6,7,* 1 School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa; [email protected] 2 School of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Durban 4001, South Africa; [email protected] 3 Department of Statistics, College of Science, Bahir Dar University, Bahir Dar 6000, Ethiopia 4 Infectious Diseases and Anti-Infective Therapy Research Group, Sharjah Medical Research Institute and College of Pharmacy, University of Sharjah, Sharjah 27272, UAE; [email protected] 5 Department of Medicine, School of Medicine, University of California, Irvine, CA 92868, USA 6 Zoonosis Science Center, Department of Medical Biochemistry and Microbiology, Uppsala University, SE 75185 Uppsala, Sweden 7 Division of Virology, Department of Infectious Diseases and St. Jude Center of Excellence for Influenza Research and Surveillance (CEIRS), St Jude Children Research Hospital, Memphis, TN 38105, USA * Correspondence: [email protected] Received: 17 February 2020; Accepted: 7 April 2020; Published: 20 April 2020 Abstract: Emerging and re-emerging viral diseases are of great public health concern. The recent emergence of Severe Acute Respiratory Syndrome (SARS) related coronavirus (SARS-CoV-2) in December 2019 in China, which causes COVID-19 disease in humans, and its current spread to several countries, leading to the first pandemic in history to be caused by a coronavirus, highlights the significance of zoonotic viral diseases.
    [Show full text]
  • Competency of Amphibians and Reptiles and Their Potential Role As Reservoir Hosts for Rift Valley Fever Virus
    viruses Article Competency of Amphibians and Reptiles and Their Potential Role as Reservoir Hosts for Rift Valley Fever Virus Melanie Rissmann 1, Nils Kley 1, Reiner Ulrich 2,3 , Franziska Stoek 1, Anne Balkema-Buschmann 1 , Martin Eiden 1 and Martin H. Groschup 1,* 1 Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, 17493 Greifswald-Insel Riems, Germany; melanie.rissmann@fli.de (M.R.); [email protected] (N.K.); franziska.stoek@fli.de (F.S.); anne.balkema-buschmann@fli.de (A.B.-B.); martin.eiden@fli.de (M.E.) 2 Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, 17493 Greifswald-Insel Riems, Germany; [email protected] 3 Institute of Veterinary Pathology, Leipzig University, 04103 Leipzig, Germany * Correspondence: martin.groschup@fli.de; Tel.: +49-38351-7-1163 Received: 10 September 2020; Accepted: 19 October 2020; Published: 23 October 2020 Abstract: Rift Valley fever phlebovirus (RVFV) is an arthropod-borne zoonotic pathogen, which is endemic in Africa, causing large epidemics, characterized by severe diseases in ruminants but also in humans. As in vitro and field investigations proposed amphibians and reptiles to potentially play a role in the enzootic amplification of the virus, we experimentally infected African common toads and common agamas with two RVFV strains. Lymph or sera, as well as oral, cutaneous and anal swabs were collected from the challenged animals to investigate seroconversion, viremia and virus shedding. Furthermore, groups of animals were euthanized 3, 10 and 21 days post-infection (dpi) to examine viral loads in different tissues during the infection. Our data show for the first time that toads are refractory to RVFV infection, showing neither seroconversion, viremia, shedding nor tissue manifestation.
    [Show full text]
  • Rift Valley Fever in Kenya: Policies to Prepare and Respond
    Rift Valley fever in Kenya: policies to prepare and respond From the project “Re-emerging transmissible STEPS briefing transboundary animal diseases: comparing Rift Valley Fever with BSE”, November 2014 Introduction Our approach to Rift Valley fever (RVF) in Kenya has No figures are yet available for the 2014 West African been informed by a recognition that the experience with Ebola outbreak, but for BSE, an investment by the British diseases such as Ebola in West Africa and BSE in the UK government in 1986, when BSE first emerged, of some demonstrate that the costs of responding to outbreaks of £20 million pounds in disease eradication, would have transmissible and infectious diseases, especially zoonotic avoided eventual costs to the UK government of some infections that can infect both animals and people, can be £20 billion, without including costs borne by households far greater than the cost of implementing measures to and farmers. A thousand-fold return on a public control or prevent problems in the first place. investment is above average, but the general point remains namely that failing to make prudent preparations can be very costly in human and economic terms. Sheep and goats being vaccinated against RVF-Photo by Omar Chatsi Omar by RVF-Photo against vaccinated being goats and Sheep Rift Valley fever in Kenya: policies to prepare and respond 2 RVF – a case study of a zoonotic disease Rift Valley fever (RVF) is a seriously unpleasant disease Our study has focussed on exploring diverse ways in that can infect human beings as well as susceptible which pastoralists, policy-makers and those responsible species, including cattle, sheep, goats, camels and for veterinary and public health can better respond to the wildlife.
    [Show full text]
  • Rift Valley Fever Division of Disease Control What Do I Need to Know?
    Division of Disease Control What Do I Need to Know? Rift Valley Fever (RVF) What is Rift Valley Fever? Rift Valley fever (RVF) is an acute, fever-causing viral disease that affects domestic animals (such as cattle, buffalo, sheep, goats and camels) and humans. RVF is most commonly associated with mosquito-borne epidemics during years of unusually heavy rainfall in the eastern and southern regions of Africa. The disease is caused by the RVF virus, a member of the genus Phlebovirus in the family Bunyaviridae. The disease was first reported among livestock by veterinary officers in Kenya in the early 1900s. Who is at risk for Rift Valley Fever? Anyone who is exposed to infected mosquitoes can get RVF. However, more commonly, people are infected after exposure to blood, body fluids and tissues of infected animals. What are the symptoms of Rift Valley Fever? RVF virus can cause several different disease syndromes. However, those infected with RVF typically have either no symptoms or a mild illness associated with fever and liver abnormalities. Patients who become ill usually experience fever, generalized weakness, back pain, dizziness, and extreme weight loss at the onset of the illness. Typically, patients recover within two days to one week after onset of illness. However, a small percent (8-10%) of people can develop more serious forms of the illness including the following: Hemorrhagic fever occurs in less than 1 percent of people and may lead to shock, jaundice, and bleeding from the gums, skin and nose. The fatality rate for those who develop hemorrhagic fever approaches 50%.
    [Show full text]
  • Rift Valley Fever Center for Food Security and Public Health 2011 1
    Rift Valley Fever S l i d Rift Valley Fever e Infectious Enzootic Hepatitis of Sheep and Cattle 1 S In today’s presentation we will cover information regarding the l Overview organism that causes Rift Valley fever and its epidemiology. We will i • Organism also talk about the history of the disease, how it is transmitted, species d • History that it affects (including humans), and clinical and necropsy signs e • Epidemiology observed. Finally, we will address prevention and control measures for • Transmission Rift Valley fever virus. • Disease in Humans 2 • Disease in Animals • Prevention and Control Center for Food Security and Public Health, Iowa State University, 2011 S l i d e THE ORGANISM 3 S Rift Valley fever (RVF) is caused by a Phlebovirus (Family l The Virus Bunyaviridae). It is a three stranded RNA virus and requires a mosquito o i • Phlebovirus, Bunyaviridae vector. The virus is very stable at temperatures from -60 to 23 C and at d • Stable at 50 to 85% relative humidity. It is inactivated by lipid solvents, – -60oC to 23°C detergents and low pH. e – 50 to 85% relative humidity • Inactivated by: Photo: Electron micrograph of the Rift Valley fever virus (RVFV), 4 – Lipid solvents – Detergents CDC. – Low pH Center for Food Security and Public Health, Iowa State University, 2011 S Rift Valley fever is an acute febrile disease that severely affects sheep, l Disease Overview cattle and goats, especially young animals. There is a very high rate of i • Acute febrile disease abortion and death in neonates. RVF can also affect humans.
    [Show full text]
  • Rift Valley Fever
    Rift Valley fever (RVF) is a viral disease spread to A Rift Valley Fever outbreak was successfully predicted livestock (cattle, sheep, goats and camels) and humans several months in advance for the first time with a model via mosquitoes that transmit the virus through biting. developed by a team assembled by USDA-ARS scientists. This disease is a major human, agricultural and economic In October 2006, when the model predicted that RVF threat in Africa and the Middle East. It has not reached would flare up within 3 months in sub-Saharan Africa, a the United States, but having a way to predict potential warning was sent to FAO and WHO, which then passed outbreaks allows the United States to implement on the warning to countries such as Kenya, Ethiopia, preventive measures. The rapid spread of West Nile Tanzania, Uganda and Somalia. The early warning allowed virus—once only prevalent in Africa—demonstrates the the countries most likely to be in harm’s way to step up nature of disease threats, and the importance of being able surveillance and controls for disease-carrying insects. to track and prevent insect-transmitted diseases. Subsequently, from 2007–2010, additional specific warnings were issued to Sudan, Southern Africa and USDA-ARS researchers partnered with the United Nations Madagascar months prior to the detection of RVF disease Food and Agriculture Organization (FAO), the World in animals and people. Health Organization (WHO) and Federal partners from NASA, CDC and the DoD to form the Rift Valley Fever An outbreak of Rift Valley Fever was blamed for the Outbreak Early-Warning Team in a global effort to develop deaths of hundreds of people in Kenya in 1997–1998.
    [Show full text]
  • Target Product Profiles for Rift Valley Fever Virus Vaccines
    Target Product Profiles for Rift Valley Fever Virus Vaccines 2019 Version 3 1 2 3 4 WHO Target Product Profiles for Rift Valley Fever Virus Vaccines 5 6 2019 7 8 9 Purpose of the document 10 Because of its potential to cause a public health emergency and the absence of an efficacious vaccine, Rift 11 Valley Fever (RVF) is a WHO priority disease for which accelerated vaccine research and development is 12 urgently required1. As part of the WHO R&D Blueprint for Action to Prevent Epidemics, these Target 13 Product Profiles (TPPs) for Rift Valley Fever Virus Vaccines (hereinafter the ‘TPP Guideline’) aim to provide 14 early technical guidance for development of a vaccine to protect human public health interests. TPPs are 15 provided for human vaccines for reactive use in outbreak settings with rapid onset of immunity and for 16 long term protection of persons at high ongoing risk. With respect to the TPP for a veterinary vaccine, 17 characteristics have been set to limit an RVF outbreak in the animal population and to preclude virus 18 transmission from the animal reservoir to humans. The extent of the veterinary TPP has been limited to 19 ruminants for this preliminary draft, however the fact that RVF can infect various animal species both 20 within livestock and wild animals will be addressed in a later version. 21 This TPP Guideline is meant for private and public parties that are professionally involved in the 22 development and eventual production of a vaccine against RVF and to facilitate the most expeditious 23 development of vaccine candidates against RVF.
    [Show full text]
  • West Nile Fever, Rift Valley Fever, Japanese Encephalitis and Crimean-Congo Haemorrhagic Fever
    Rev. sci. tech. Off. int. Epiz., 2004, 23 (2), 535-555 Epidemiological processes involved in the emergence of vector-borne diseases: West Nile fever, Rift Valley fever, Japanese encephalitis and Crimean-Congo haemorrhagic fever V. Chevalier, S. de la Rocque, T. Baldet, L. Vial & F. Roger Centre de coopération internationale en recherche agronomique pour le développement (CIRAD), Campus International de Baillarguet, 34398 Montpellier Cedex 5, France Summary Over the past few decades, the geographical distribution of arthropod-borne zoonoses has dramatically expanded. The influence of human-induced or ecological changes on the risk of disease outbreaks is undeniable. However, few hypotheses have been proposed which address the re-emergence of these diseases, the spread of these viruses to previously uninfected areas and their establishment therein. Host and vector movements play an important role in the dissemination of pathogens, and the ability of these diseases to colonise previously uninfected areas may be explained by the diversity of hosts and vectors, the presence of favourable ecological conditions, and the successful adaptations of vectors or pathogens to new ecosystems. The objective of this paper is to describe the epidemiological processes of the vector-borne diseases Rift Valley fever, West Nile fever, Japanese encephalitis and Crimean-Congo haemorrhagic fever. Keywords Crimean-Congo haemorrhagic fever – Dissemination – Diversity – Emerging disease – Epidemiological process – Japanese encephalitis – Rift Valley fever – Vector – West Nile fever. Introduction Over the past few decades, significant changes in the distribution and vector-host contact, long distance distribution and intensity of major vector-borne zoonotic transportation of arboviruses has also been described. It diseases have been recorded.
    [Show full text]
  • Over 100 Years of Rift Valley Fever: a Patchwork of Data on Pathogen Spread and Spillover
    medRxiv preprint doi: https://doi.org/10.1101/2021.02.18.21251916; this version posted February 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Over 100 years of Rift Valley Fever: a patchwork of data on pathogen spread and spillover 1* 2 3 2 2 2 Gebbiena M. Bron ,​ Kathryn Strimbu ,​ Hélène Cecilia ,​ Anita Lerch ,​ Sean Moore ,​ Quan Tran ,​ T. 2 ​ ​ 1*​ ​ ​ ​ ​ ​ Alex Perkins ​ and Quirine A. ten Bosch ​ ​ 1. Wageningen University and Research, Quantitative Veterinary Epidemiology, Wageningen, The Netherlands 2. University of Notre Dame, Department of Biological Sciences and Eck Institute for Global Health, ​ Notre Dame, IN, USA 3. INRAE, Oniris, BIOEPAR, 44300, Nantes, France * Correspondence: [email protected]; [email protected]; +31 (0) 317 482335 ​ ​ ​ ​ ​ Abstract: During the past 100 years, Rift Valley fever virus (RVFV), a mosquito-borne virus, has ​ ​ ​ caused potentially lethal disease in livestock, and has been associated with significant economic losses and trade bans. Spillover to humans occurs and can be fatal. Here, we combined data on RVF ​ disease in humans (22 countries) and animals (37 countries) from 1931 to 2020 with ​ seroprevalence studies from 1950 to 2020 (N=226) from publicly available databases and ​ publications to further the understanding of RVFV epidemiology. RVFV has spread from its original ​ ​ ​ focus in Kenya throughout Africa. In 2000, RVFV was first detected in the Arabian peninsula. Since ​ ​ then seropositive animals have been observed in additional countries in western Asia.
    [Show full text]
  • Rift Valley Fever: Important Considerations for Risk Mitigation and Future Outbreaks
    Tropical Medicine and Infectious Disease Review Rift Valley Fever: Important Considerations for Risk Mitigation and Future Outbreaks Elysse N. Grossi-Soyster * and A. Desiree LaBeaud * Department of Pediatrics, Division of Infectious Disease, Stanford University School of Medicine, Stanford, CA 94305, USA * Correspondence: [email protected] (E.N.G.-S.); [email protected] (A.D.L.) Received: 1 May 2020; Accepted: 28 May 2020; Published: 2 June 2020 Abstract: Rift Valley fever virus (RVFV) is a zoonotic phlebovirus of the Phenuiviridae family with great opportunity for emergence in previously unaffected regions, despite its current geographical limits. Outbreaks of RVFV often infect humans or domesticated animals, such as livestock, concurrently and occur sporadically, ranging from localized outbreaks in villages to multi-country events that spread rapidly. The true burden of Rift Valley fever (RVF) is not well defined due to underreporting, misdiagnosis caused by the broad spectrum of disease presentation, and minimal access for rapid and accurate laboratory confirmation. Severe symptoms may include hemorrhagic fever, loss of vision, psychological impairment or disturbances, and organ failure. Those living in endemic areas and travelers should be aware of the potential for exposure to ongoing outbreaks or interepidemic transmission, and engage in behaviors to minimize exposure risks, as vaccinations in humans are currently unavailable and animal vaccinations are not used routinely or ubiquitously. The lack of vaccines approved for use in humans is concerning, as RVFV has proven to be highly pathogenic in naïve populations, causing severe disease in a large percent of confirmed cases, which could have considerable impact on human health. Keywords: Rift Valley fever (RVF); arboviruses; mosquito-borne viruses; zoonoses; One Health; travel medicine; livestock; viral emergence 1.
    [Show full text]